<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5A8E328E-8A10-45F8-9C51-6BD66C215CC0"><gtr:id>5A8E328E-8A10-45F8-9C51-6BD66C215CC0</gtr:id><gtr:name>Nottingham University Hospital NHS Trust</gtr:name><gtr:address><gtr:line1>Nottingham University HospitalMedical Physics and clinical engineeringQMC Campus</gtr:line1><gtr:city>Nottingham</gtr:city><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5A8E328E-8A10-45F8-9C51-6BD66C215CC0"><gtr:id>5A8E328E-8A10-45F8-9C51-6BD66C215CC0</gtr:id><gtr:name>Nottingham University Hospital NHS Trust</gtr:name><gtr:address><gtr:line1>Nottingham University HospitalMedical Physics and clinical engineeringQMC Campus</gtr:line1><gtr:city>Nottingham</gtr:city><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DFAD4DDC-5E5A-4D17-97EF-683E1ADB367C"><gtr:id>DFAD4DDC-5E5A-4D17-97EF-683E1ADB367C</gtr:id><gtr:firstName>Heather</gtr:firstName><gtr:surname>Fortnum</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3CEB4C9F-4AE7-4B8D-BF98-FE39E5D804DE"><gtr:id>3CEB4C9F-4AE7-4B8D-BF98-FE39E5D804DE</gtr:id><gtr:firstName>John P</gtr:firstName><gtr:surname>Birchall</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7BE87EE3-47DA-4714-9C8D-5227CD73F822"><gtr:id>7BE87EE3-47DA-4714-9C8D-5227CD73F822</gtr:id><gtr:firstName>Roger</gtr:firstName><gtr:surname>Bayston</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6F873466-E951-4C32-9C93-A2EF14CC95FD"><gtr:id>6F873466-E951-4C32-9C93-A2EF14CC95FD</gtr:id><gtr:firstName>Matija</gtr:firstName><gtr:surname>Daniel</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4A9AA458-F9A0-43EC-9726-86676F718F98"><gtr:id>4A9AA458-F9A0-43EC-9726-86676F718F98</gtr:id><gtr:firstName>Kevin</gtr:firstName><gtr:surname>Shakesheff</gtr:surname><gtr:orcidId>0000-0003-3236-2439</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902230"><gtr:id>970892F8-C7FA-4395-922D-D3C782786681</gtr:id><gtr:title>Slow-Release Antibiotic Middle Ear Implant for Glue Ear Treatment</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0902230</gtr:grantReference><gtr:abstractText>Glue ear is a common cause of deafness in childhood, affecting up to 75% of children. It is caused by persistent bacterial infection (biofilm) that is impossible to cure with traditional antibiotic treatment, but can be resolved with a prolonged course of high dose antibiotics given directly to the affected area. The current treatment of severe persistent glue ear consists of grommet (ventilation tube) insertion, but although this is the commonest surgical procedure in children, it only removes the glue fluid and does not address the underlying problem of bacterial biofilm infection. Therefore, a quarter of children require further grommet insertion within 2 years of initial surgery, and management of glue ear and its long-term complications presents a significant problem and workload to the clinician.
We plan to investigate a novel alternative strategy for glue ear treatment, by developing a slow-release antibiotic implant that can be inserted into the middle ear to release antibiotics at a high dose over a prolonged period of time to eradicate infection. This project in a laboratory setting will develop the slow-release antibiotic implant and test its effectiveness against bacterial biofilm infection.</gtr:abstractText><gtr:technicalSummary>BACKGROUND: Otitis media with effusion (OME, glue ear) is a common cause of hearing loss in childhood, affecting up to 75% of children, and treatment with grommets (ventilation tube) insertion is the commonest indication for surgery in children. OME is thought to be caused by bacterial infection, with bacteria persisting in the middle ear as biofilms (adherent three-dimensional structured communities of bacteria growing in a self-produced extracellular matrix). Such bacteria are recalcitrant (resistant) to conventional antibiotic treatments, accounting for the failure of oral antibiotics to confer a lasting benefit in children with OME. However, whilst grommet insertion removes glue (a product of increased mucous production by the middle ear mucosa irritated by bacterial presence), it does not address the underlying problem of bacterial infection. Therefore, a quarter of children require further grommet insertion within 2 years of initial surgery.
AIM: We plan to investigate a novel alternative strategy for glue ear treatment, by developing a slow-release antibiotic implant that can be inserted into the middle ear to release antibiotics at a high dose over a prolonged period of time to eradicate infection.
METHODS: This laboratory project will optimise the formulation for surgical handling. Antibiotic release will be assessed using serial dilution and High Performance Liquid Chromatography. Microbiological effectiveness will be assessed using minimum inhibitory concentration agar plate assay, and biofilms cultured on silicone tubing will be used to assess effectiveness of the antibiotic implant against established biofilms in a novel in vitro model
POTENTIAL APPLICATION: If successful, we would expect patients to benefit from this research within less than 5 years. The antibiotic implant may reduce recurrence of OME and associated long-term complications including hearing loss, and may replace the need for grommet insertion with a simpler procedure involving just the placement of the antibiotic implant. As the project uses existing antibiotics and slow-release techniques for a new application, better treatment of glue ear could be developed at very little cost. Following laboratory research, a clinical trial would be planned in association with the National Biomedical Unit in Hearing.</gtr:technicalSummary><gtr:fund><gtr:end>2011-04-19</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-04-20</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>116325</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medicine, Biological Sciences and Psychology</gtr:department><gtr:description>Pellet toxicity</gtr:description><gtr:id>3F70F655-F9B0-4585-9894-8305BBAE9603</gtr:id><gtr:impact>none to date</gtr:impact><gtr:outcomeId>PpidmJ6BSr3-1</gtr:outcomeId><gtr:partnerContribution>Middle and inner ear toxicity expertise</gtr:partnerContribution><gtr:piContribution>Biofilm and drug delivery expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Molecular Medical Sciences Nottingham</gtr:department><gtr:description>Antibiotic pellets</gtr:description><gtr:id>AD151B87-3718-4CCE-A2BA-BBF6C2086B05</gtr:id><gtr:impact>Output from research project as a whole is the result of collaboration. The work has led to numerous national and international presentations. The project is multidisciplinary, involving departments of Otolaryngology (University and NHS), Othopaedic and Accident Surgey / Biomaterials-Related Infection Group, School of Pharmacy, and the National Biomedical Research Unit in Hearing.</gtr:impact><gtr:outcomeId>GBArs4v8MNr-2</gtr:outcomeId><gtr:partnerContribution>Access to facilities. Intellectual contributionAccess to facilities. Intellectual contributionIntellectual input</gtr:partnerContribution><gtr:piContribution>Carried out the actual work, led the project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>Antibiotic pellets</gtr:description><gtr:id>8103966E-27F3-4018-A69C-39BB3FBCE151</gtr:id><gtr:impact>Output from research project as a whole is the result of collaboration. The work has led to numerous national and international presentations. The project is multidisciplinary, involving departments of Otolaryngology (University and NHS), Othopaedic and Accident Surgey / Biomaterials-Related Infection Group, School of Pharmacy, and the National Biomedical Research Unit in Hearing.</gtr:impact><gtr:outcomeId>GBArs4v8MNr-1</gtr:outcomeId><gtr:partnerContribution>Access to facilities. Intellectual contributionAccess to facilities. Intellectual contributionIntellectual input</gtr:partnerContribution><gtr:piContribution>Carried out the actual work, led the project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biomedical Sciences Nottingham</gtr:department><gtr:description>Antibiotic pellets</gtr:description><gtr:id>283C8AA3-D61F-4282-9492-14DEE3157844</gtr:id><gtr:impact>Output from research project as a whole is the result of collaboration. The work has led to numerous national and international presentations. The project is multidisciplinary, involving departments of Otolaryngology (University and NHS), Othopaedic and Accident Surgey / Biomaterials-Related Infection Group, School of Pharmacy, and the National Biomedical Research Unit in Hearing.</gtr:impact><gtr:outcomeId>GBArs4v8MNr-3</gtr:outcomeId><gtr:partnerContribution>Access to facilities. Intellectual contributionAccess to facilities. Intellectual contributionIntellectual input</gtr:partnerContribution><gtr:piContribution>Carried out the actual work, led the project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nottingham University Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nottingham University Hospitals Charity</gtr:department><gtr:description>Antibiotic pellets</gtr:description><gtr:id>6B9DEA93-12FA-4DC7-95FF-915CE444BB97</gtr:id><gtr:impact>Output from research project as a whole is the result of collaboration. The work has led to numerous national and international presentations. The project is multidisciplinary, involving departments of Otolaryngology (University and NHS), Othopaedic and Accident Surgey / Biomaterials-Related Infection Group, School of Pharmacy, and the National Biomedical Research Unit in Hearing.</gtr:impact><gtr:outcomeId>GBArs4v8MNr-4</gtr:outcomeId><gtr:partnerContribution>Access to facilities. Intellectual contributionAccess to facilities. Intellectual contributionIntellectual input</gtr:partnerContribution><gtr:piContribution>Carried out the actual work, led the project</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>F223FDC4-AF6A-4205-9409-81734302A1A2</gtr:id><gtr:impact>Report on local news, press release

Publicity to local public, press release on line</gtr:impact><gtr:outcomeId>skPdT9yAAiV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>9314</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant / Mason Medical</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Mason Medical Research Foundation</gtr:fundingOrg><gtr:id>F1B89C41-E35D-41F0-A546-BF475AED1E94</gtr:id><gtr:outcomeId>iLhyi2MnArN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant / Sir Samuel Scott of Yews</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Sir Samuel Scott of Yews Trust</gtr:fundingOrg><gtr:id>77A966EC-9FA5-4FCF-9B3E-56D4903B36D6</gtr:id><gtr:outcomeId>fA4zCc9ihM20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant / MIO</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>The Midland Institute of Otology</gtr:fundingOrg><gtr:id>35D0DCCC-6E7B-4D3D-838A-B52BC087C662</gtr:id><gtr:outcomeId>JuoVfZiuQTA0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Antibiotic pellet tested in vitro against biofilms (with ultimate clinical aim of treating glue ear). The product as it stands needs refinement and is not suitable for clinical trials at this stage. Principally funded by MRC</gtr:description><gtr:id>266FE23C-2FB4-44D3-8729-99437F2F9DEC</gtr:id><gtr:impact>At present stage the product needs further refinement.</gtr:impact><gtr:outcomeId>mF7JyrY8srb</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>Antibiotic pellet</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>In vitro biofilm model to study biofilms implicated in glue ear</gtr:description><gtr:id>306D8067-CBD5-4631-893B-FF4753C2F266</gtr:id><gtr:impact>The model allowed our group to study biofilms in vitro without need for animal studies</gtr:impact><gtr:outcomeId>kCACPAR1avb</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Biofilm model</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D20E9F3F-97A5-4946-88C9-7431080D39C2</gtr:id><gtr:title>Drug delivery to the ear.</gtr:title><gtr:parentPublicationTitle>Therapeutic delivery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0969c991257c1d6e5ac76f0d0dc6de3d"><gtr:id>0969c991257c1d6e5ac76f0d0dc6de3d</gtr:id><gtr:otherNames>Hoskison E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-5990</gtr:issn><gtr:outcomeId>hRbrWusY5cP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1F675F8-F9E9-434E-81E9-D5FB258561AE</gtr:id><gtr:title>Biofilm eradication with biodegradable modified-release antibiotic pellets: a potential treatment for glue ear.</gtr:title><gtr:parentPublicationTitle>Archives of otolaryngology--head &amp; neck surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf048527669c8a224f7ce76455ec037"><gtr:id>edf048527669c8a224f7ce76455ec037</gtr:id><gtr:otherNames>Daniel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0886-4470</gtr:issn><gtr:outcomeId>jgikRfTehMj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1FAE88A-5B54-4044-85C4-DD90C156BCBD</gtr:id><gtr:title>Development of an in-vitro model of Staphylococcus aureus biofilm infection with a focus on reduced susceptibility to antibiotics</gtr:title><gtr:parentPublicationTitle>J Hosp Infect</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bad2686a73a368fe152b86a06bbbedf3"><gtr:id>bad2686a73a368fe152b86a06bbbedf3</gtr:id><gtr:otherNames>Daniel, Matija</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>Z3ogEuWJTmP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C9CF76C-4A15-4487-8FC2-1F4677508526</gtr:id><gtr:title>Bacterial involvement in otitis media with effusion.</gtr:title><gtr:parentPublicationTitle>International journal of pediatric otorhinolaryngology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edf048527669c8a224f7ce76455ec037"><gtr:id>edf048527669c8a224f7ce76455ec037</gtr:id><gtr:otherNames>Daniel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0165-5876</gtr:issn><gtr:outcomeId>bQ8Rkkr5ag6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C0F2C1B-A734-436B-A7A0-0082A3C68EF3</gtr:id><gtr:title>Update on otitis media - prevention and treatment.</gtr:title><gtr:parentPublicationTitle>Infection and drug resistance</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/096c939ba6bc7336a1e6d19436d3fe40"><gtr:id>096c939ba6bc7336a1e6d19436d3fe40</gtr:id><gtr:otherNames>Qureishi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1178-6973</gtr:issn><gtr:outcomeId>563f98ca76b3b7.67115540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79036CB4-78D1-466C-B71C-6206BB62AD63</gtr:id><gtr:title>Do orally administered antibiotics reach concentrations in the middle ear sufficient to eradicate planktonic and biofilm bacteria? A review.</gtr:title><gtr:parentPublicationTitle>International journal of pediatric otorhinolaryngology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34c122fbb02452d19f3f8891b90baf89"><gtr:id>34c122fbb02452d19f3f8891b90baf89</gtr:id><gtr:otherNames>Belfield K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0165-5876</gtr:issn><gtr:outcomeId>563f98ca5046e1.03490226</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902230</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>5585DDA6-FCF6-4B64-8332-1BDFE62CE94E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Ear</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93E3E424-8678-4BDD-9675-2EA16B3EFEA4</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.3  Medical devices</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>